Associate Professor of Behavioral Science and Psychiatry, Bell Alcohol and Addictions Chair, Medical Director of First Bridge and Straus Clinics
University of Kentucky College of Medicine/Center on Drug and Alcohol Research
Lexington, Kentucky
Dr. Michelle Lofwall has focused her entire career on addiction treatment, specializing in medications for opioid use disorder, as not only a treatment provider, but also an educator and researcher. Dr. Lofwall currently serves as one of the lead investigators on the opioid use disorder (OUD) treatment team of the NIH HEALing Communities Study that is working to increase patient entry and retention in evidence-based care through community providers, which includes several of KY's OTPs. Dr. Lofwall, an associate professor of behavioral science and psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky College of Medicine, is also the Medical Director for the Robert Straus Clinic and the First Bridge Clinic at UK, which provides rapid access to comprehensive opioid use disorder treatment for patients with serious health complications.
Dr. Lofwall’s research is nationally recognized and has focused on improving treatment of individuals with substance use disorders and evaluation of novel treatments for opioid use disorder. Dr. Lofwall also served on an expert panel for the development of SAMHSA’s Treatment Improvement Protocol (TIP 63) for Medication Treatment of OUD. Dr. Lofwall was also elected as a Distinguished Fellow of American Society of Addiction Medicine (ASAM) and the American Psychiatric Association and is co-director of the American Academy of Addiction Psychiatry’s annual addiction treatment review course.
Wednesday, November 2, 2022
8:45 AM – 9:15 AM